UPSHER SMITH LABS FDA Approval ANDA 212333

ANDA 212333

UPSHER SMITH LABS

FDA Drug Application

Application #212333

Documents

Letter2021-05-06

Application Sponsors

ANDA 212333UPSHER SMITH LABS

Marketing Status

None (Tentative Approval)001
Prescription002
Prescription003

Application Products

001CAPSULE;ORAL10MG0ISOTRETINOINISOTRETINOIN
002CAPSULE;ORAL20MG0ISOTRETINOINISOTRETINOIN
003CAPSULE;ORAL30MG0ISOTRETINOINISOTRETINOIN

FDA Submissions

UNKNOWN; ORIG1TA2021-04-12STANDARD
LABELING; LabelingSUPPL3AP2022-08-24STANDARD
REMS; REMSSUPPL6AP2022-10-06

Submissions Property Types

ORIG1Null31
SUPPL3Null15
SUPPL6Null7

TE Codes

001PrescriptionAB2
002PrescriptionAB2
003PrescriptionAB2

CDER Filings

UPSHER SMITH LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212333
            [companyName] => UPSHER SMITH LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"ISOTRETINOIN","activeIngredients":"ISOTRETINOIN","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/12\/2021","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-04-12
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.